Assessment of cell proliferation in benign, premalignant and malignant skin lesions

Applied Immunohistochemistry and Molecular Morphology

Volumn 15, Issue 2, 2007, Pages 229-235

  Bordbar, Arash ^a   Dias, Dwen ^b   Cabral, Ailton ^c   Beck, Samuel ^a   Boon, Mathilde E ^a  

^a LEIDEN CYTOLOGY AND PATHOLOGY LABORATORY   (Netherlands)

^b GOA MEDICAL COLLEGE   (India)

^c Araújo Jorge Hospital of the Goiás Anticancer Association   (Brazil)

Author keywords

Actinic keratosis; Bowen disease; Keratoacanthoma; MIB 1; SCC

Indexed keywords

COMPLEMENTARY DNA; KI 67 ANTIGEN;

ACTINIC KERATOSIS; ARTICLE; BASEMENT MEMBRANE; BOWEN DISEASE; CELL POLARITY; CELL PROLIFERATION; CONTROLLED STUDY; EPIDERMIS; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; KERATOACANTHOMA; MALIGNANT NEOPLASTIC DISEASE; PRECANCER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA;

ANTIBODIES, ANTINUCLEAR; ANTIBODIES, MONOCLONAL; BOWEN'S DISEASE; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; HUMANS; KERATOACANTHOMA; KERATOSIS; KI-67 ANTIGEN; NEOPLASMS; PRECANCEROUS CONDITIONS; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 34249663292     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/01.pai.0000209867.20581.c7     Document Type: Article

References (34)

1. Bishop JM. The molecular genetics of cancers. Science. 1987;235:305-311.
2. Werness BA, Levine AJ, Howley PM. Association of Human papillomavirus type 16 and 18 E6 protein with p53. Science. 1990;248:76-79.
3. Dyson N, Howley PM, Munger K, et al. The human papillomavirus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934-937.
4. Johnson TM, Rowe DE, Nelson BR, et al. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol. 1992;26:467-484.
5. Oh, Chee Won, Penneys, Neal. P27 and MiB1 expression in actinic keratosis, Bowen's disease, and Squamous cell carcinoma. Am J Dermatopathol. 2004;26:22-26.
6. Fulton J. Actinic keratosis. Online publication at http://www. emedicine.com/derm/topic9.htm.
7. Berner A. Actinic keratosis and development of cutaneous squamous cell carcinoma. Tidsskr Nor Laegeforen. 2005;125:1653-1654.
8. Fu W, Cockerell CJ. The actinic (solar) keratosis: a 21st-century perspective. Arch Dermatol. 2003;139:66-70.
9. LeBoit PE. Can we understand keratoacanthoma? Am J Dermatopathol. 2002;24:166-168.
10. Adachi A, Suzuki T, Tomita Y. Detection of human papillomavirus type 56 DNA, belonging to a mucous high-risk group, in hair follicles in the genital area of a woman no longer suffering from viral warts. J Cutan Pathol. 2003;30:423-429.
11. Forslund O, DeAngelis PM, Beigi M, et al. Identification of human papillomavirus in keratoacanthomas. J Cutan Pathol. 2003;30:423-429.
12. Weidner N, Moore DH 2nd, Vartanian R. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody. Hum Pathol. 1994;25:337-342.
13. Matsuta M, Kimura S, Kosegawa G. Immunohistochemical detection of Ki-67 in epithelial skin tumors in formalin-fixed paraffin-embedded tissue sections using a new monoclonal antibody (MIB-1). J Dermatol. 1996;23:147-152.
14. Klein-Szanto AJ, Barr RJ, Reiners JJ Jr, et al. Filaggrin distribution in keratoacanthomas and squamous cell carcinoma. Arch Pathol Lab Med. 1984;108:888-889.
15. Ho T, Horn T, Finzi E. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas. Arch Dermatol. 1991;127:1167-1171.
16. Melendez ND, Smoller BR, Morgan M. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas. Mod Pathol. 2003;16:8-13.
17. Phillips P, Helm KF. Proliferating cell nuclear antigen distribution in keratoacanthoma and squamous cell carcinoma. J Cutan Pathol. 1993;20:424-428.
18. Pilch H, Weiss J, Heubner C, et al. Differential diagnosis of keratoacanthomas and squamous cell carcinomas: diagnostic value of DNA image cytometry and p53 expression. J Cutan Pathol. 1994;21:507-513.
19. Randall MB, Geisinger KR, Kute TE, et al. DNA content and proliferative index in cutaneous squamous cell carcinoma and keratoacanthoma. Am J Clin Pathol. 1990;93:259-262.
20. Cain CT, Niemann TH, Argenyi ZB. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors. Am J Dermatopathol. 1995;17:324-331.
21. Teh M, Lee YS. An immunohistochemical study of p53 protein in the different histological subtypes of gastric carcinoma. Pathology. 1994;26:432-434.
22. Biesterfeld S, Josef J. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry. Anticancer Res. 2002;22:3019-3023.
23. Cabral A, van Haaften C, Boon ME. Proliferation patterns reflect architectural dedifferentiation: a study of nodular basal cell carcinoma. J Dermatol. 2004;31:305-313.
24. Kok LP, Boon ME. Microwaves for the Art of Microscopy. 4th revised edition. Leiden: Coulomb Press Leyden; 2003.
25. Surowiak P, Pudelko M, Maciejczyk A, et al. The relationship of the expression of proliferetron-related antigens Ki67 and PCNA in the cells of ductal breast cancer with the differentiation grade. Ginekol Pol. 2005;76:9-14.
26. Boon ME, Schmidt U, Cramer-Knijnenburg GI, et al. Using Kryofix as alternative for formalin results in more optimal and standardized immunostaining of paraffin sections. Pathol Res Pract. 1992;1887:832-835.
27. Frost AR, Sparks D, Grizzle WE. Methods of antigen recovery vary in their usefulness in unmasking specific antigens in immunohistochemistry. Appl Immunohistochem Mol Morphol. 2000;8:236-243.
28. Lu S, Tiekso J, Hietanen S. Expression of cell-cycle proteins p53, p21 (WAF-1), PCNA, and Ki-67 in benign, premalignant and malignant skin lesions with implicated HPV involvement. Acta Derm Venereol. 1999;79:268-273.
29. Healy E, Angus B, Lawrence CM, et al. Prognostic value of Ki 67 antigen expression in basal cell carcinomas. Br J Dermatopathol. 1995;133:737-741.
30. Gerdes J, Lemke H, Baisch H, et al. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710-1715.
31. Lu S, Syrjanen K, Havu VK, et al. No evidence of human papillomavirus DNA in actinic keratosis. Arch Dermatol Res. 1995;287:649-651.
32. Kawashima M, Favre M, Jablonska S, et al. Characterization of a new type of human papillomavirus (HPV) related to HPV5 from a case of actinic keratosis. Virology. 1986;154:389-394.
33. Mitsuishi T, Kawana S, Kato T, et al. Human papillomavirus infection in actinic keratosis and Bowen's disease: comparative study with expression of cell-cycle regulatory proteins p21(Waf1/Cip1), p53, PCNA, Ki-67, and Bcl-2 in positive and negative lesions. Hum Pathol. 2003;34:886-892.
34. Diaz-Cascajo C, Borghi S, Weyers W, et al. Follicular squamous cell carcinoma of the skin: a poorly recognized neoplasm arising from the wall of hair follicles. J Cutan Pathol. 2004;31:19-25.